NCT05889585View on ClinicalTrials.gov

Morbidity, Long-term Side Effects and Quality of Life in Germ-cell Tumor Long Survivors Treated with High-dose Chemotherapy and Autologous Stem Cell Transplant

NARecruitingINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

May 31, 2023

Primary Completion Date

May 31, 2025

Study Completion Date

May 31, 2025

Conditions
Germ Cell Tumor
Interventions
OTHER

quality of life questionnaire

EORTC-QLQ C-30 questionnaire The Impact of Events Scale (IES-R) Multi-Dimensional Fatigue Inventory The EORTC-QLQ C-30 Vers. 3

Trial Locations (1)

94805

RECRUITING

Gustave Roussy, Villejuif

All Listed Sponsors
lead

Gustave Roussy, Cancer Campus, Grand Paris

OTHER